These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38408961)

  • 21. Association of CSF Aβ
    Cullen N; Janelidze S; Palmqvist S; Stomrud E; Mattsson-Carlgren N; Hansson O;
    Neurology; 2022 Mar; 98(9):e958-e967. PubMed ID: 34937781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex differences in cognitive function trajectories and their determinants in older adults: Evidence from the Chinese longitudinal healthy longevity survey.
    Tu L; Lv X; Yuan C; Chen H; Yu X; Wang H; Zhang Q
    Int J Geriatr Psychiatry; 2024 Mar; 39(3):e6072. PubMed ID: 38488836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal Maintenance of Cognitive Health in Centenarians in the 100-plus Study.
    Beker N; Sikkes SAM; Hulsman M; Tesi N; van der Lee SJ; Scheltens P; Holstege H
    JAMA Netw Open; 2020 Feb; 3(2):e200094. PubMed ID: 32101309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dementia subtypes, cognitive decline and survival among older adults attending a memory clinic in Cape Town, South Africa: a retrospective study.
    Ssonko M; Hardy A; Naganathan V; Kalula S; Combrinck M
    BMC Geriatr; 2023 Dec; 23(1):829. PubMed ID: 38071284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Neuropsychiatric Symptom Trajectory and Conversion to Alzheimer Disease.
    Lo TWB; Karameh WK; Barfett JJ; Fornazzari LR; Munoz DG; Schweizer TA; Fischer CE;
    Alzheimer Dis Assoc Disord; 2020; 34(2):141-147. PubMed ID: 31633557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
    Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
    Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline [
    Teng E; Manser PT; Sanabria Bohorquez S; Wildsmith KR; Pickthorn K; Baker SL; Ward M; Kerchner GA; Weimer RM
    Alzheimers Res Ther; 2021 Dec; 13(1):196. PubMed ID: 34852837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
    Eikelboom WS; van den Berg E; Singleton EH; Baart SJ; Coesmans M; Leeuwis AE; Teunissen CE; van Berckel BNM; Pijnenburg YAL; Scheltens P; van der Flier WM; Ossenkoppele R; Papma JM
    Neurology; 2021 Sep; 97(13):e1276-e1287. PubMed ID: 34413181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer's disease.
    Sun N; Mormino EC; Chen J; Sabuncu MR; Yeo BTT;
    Neuroimage; 2019 Nov; 201():116043. PubMed ID: 31344486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study partner-reported decline identifies cognitive decline and dementia risk.
    Nosheny RL; Jin C; Neuhaus J; Insel PS; Mackin RS; Weiner MW;
    Ann Clin Transl Neurol; 2019 Dec; 6(12):2448-2459. PubMed ID: 31721455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late-Life Cognitive Trajectories and their Associated Lifestyle Factors.
    Yu J; Feng Q; Yu J; Zeng Y; Feng L
    J Alzheimers Dis; 2020; 73(4):1555-1563. PubMed ID: 31958087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
    J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
    Ossenkoppele R; Lyoo CH; Jester-Broms J; Sudre CH; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; La Joie R; Rabinovici GD; Hansson O
    JAMA Neurol; 2020 May; 77(5):632-642. PubMed ID: 32091549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies.
    Gonzalez MC; Ashton NJ; Gomes BF; Tovar-Rios DA; Blanc F; Karikari TK; Mollenhauer B; Pilotto A; Lemstra A; Paquet C; Abdelnour C; Kramberger MG; Bonanni L; Vandenberghe R; Hye A; Blennow K; Zetterberg H; Aarsland D;
    JAMA Neurol; 2022 Jan; 79(1):32-37. PubMed ID: 34807233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
    Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
    J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
    [No Abstract]   [Full Text] [Related]  

  • 38. Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study.
    Leoutsakos JM; Forrester SN; Corcoran CD; Norton MC; Rabins PV; Steinberg MI; Tschanz JT; Lyketsos CG
    Int J Geriatr Psychiatry; 2015 Aug; 30(8):824-32. PubMed ID: 25363393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.
    Gupta A; Kennedy K; Perales-Puchalt J; Drew D; Beddhu S; Sarnak M; Burns J;
    PLoS One; 2020; 15(10):e0239871. PubMed ID: 33036021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.